How Kesimpta is Changing the Landscape of Multiple Sclerosis Treatment
Kesimpta is revolutionizing the treatment of relapsing multiple sclerosis, offering an effective intervention through the monoclonal antibody ofatumumab. With self-administration convenience, this medication presents promising outcomes in reducing relapse rates and MRI-detected lesions. Ongoing research highlights its efficacy, especially with early administration, and underscores its viability as both a first-line and switch therapy. Explore the […]
3 minute read